Skip to content

Proteomics

Reviews

  • CITATION: Suhre, K., McCarthy, M. I., & Schwenk, J. M. (2021). Genetics meets proteomics: perspectives for large population-based studies. Nature Reviews Genetics, 22(1), 19-37.

Protein Biomarker

  • URL: https://www.olink.com/products-services/explore/
  • CITATION: Assarsson, E., Lundberg, M., Holmquist, G., Björkesten, J., Bucht Thorsen, S., Ekman, D., ... & Fredriksson, S. (2014). Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PloS one, 9(4), e95192.
  • CITATION:Wik, L., Nordberg, N., Broberg, J., Björkesten, J., Assarsson, E., Henriksson, S., ... & Lundberg, M. (2021). Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Molecular & Cellular Proteomics, 20. Screen Shot 2022-10-03 at 15 53 03

SOMAmer

  • URL: https://somalogic.com/somascan-platform/ image

  • CITATION: Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E., ... & Zichi, D. (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. Nature Precedings, 1-1.

  • CITATION: Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014). Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Molecular Therapy-Nucleic Acids, 3, e201.
  • CITATION: Candia, J., Cheung, F., Kotliarov, Y., Fantoni, G., Sellers, B., Griesman, T., ... & Biancotto, A. (2017). Assessment of variability in the SOMAscan assay. Scientific reports, 7(1), 1-13.

Comparison

  • CITATION: Katz, D. H., Robbins, J. M., Deng, S., Tahir, U. A., Bick, A. G., Pampana, A., ... & Gerszten, R. E. (2022). Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer-and antibody-based methods. Science advances, 8(33), eabm5164.
  • CITATION: Raffield, L. M., Dang, H., Pratte, K. A., Jacobson, S., Gillenwater, L. A., Ampleford, E., ... & NHLBI Trans‐Omics for Precision Medicine (TOPMed) Consortium. (2020). Comparison of proteomic assessment methods in multiple cohort studies. Proteomics, 20(12), 1900278.
  • CITATION: Pietzner, M., Wheeler, E., Carrasco-Zanini, J., Kerrison, N. D., Oerton, E., Koprulu, M., ... & Langenberg, C. (2021). Synergistic insights into human health from aptamer-and antibody-based proteomic profiling. Nature communications, 12(1), 1-13.